These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28660666)

  • 21. Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine.
    Olivera I; Grau C; Dibarboure H; Torres JP; Mieres G; Lazarov L; Alvarez FP; Yescas JGL
    BMC Health Serv Res; 2020 Apr; 20(1):295. PubMed ID: 32272920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization Policy and the Importance of Sustainable Vaccine Pricing.
    Meissner HC
    JAMA; 2016 Mar; 315(10):981-2. PubMed ID: 26857277
    [No Abstract]   [Full Text] [Related]  

  • 24. Win-win interactions between the public and private sectors.
    Batson A
    Nat Med; 1998 May; 4(5 Suppl):487-91. PubMed ID: 9585192
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccine financing and billing in practices serving adult patients: A follow-up survey.
    Lindley MC; Hurley LP; Beaty BL; Allison MA; Crane LA; Brtnikova M; Snow M; Bridges CB; Kempe A
    Vaccine; 2018 Feb; 36(8):1093-1100. PubMed ID: 29366706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine supply: a cross-national perspective.
    Danzon PM; Pereira NS; Tejwani SS
    Health Aff (Millwood); 2005; 24(3):706-17. PubMed ID: 15886165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U.S. childhood vaccine availability: legal, regulatory, and economic complexities.
    Strongin RJ
    NHPF Issue Brief; 2002 Nov; (785):1-20. PubMed ID: 12463233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Financing of Vaccine Delivery in Primary Care Practices.
    Allison MA; O'Leary ST; Lindley MC; Crane LA; Hurley LP; Beaty BL; Brtnikova M; Jimenez-Zambrano A; Babbel C; Berman S; Kempe A
    Acad Pediatr; 2017; 17(7):770-777. PubMed ID: 28600199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Private-sector vaccine purchase costs and insurer payments: a disincentive for using combination vaccines?
    Clark SJ; Cowan AE; Freed GL
    Hum Vaccin; 2011 Apr; 7(4):426-8. PubMed ID: 21389778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiered pricing of vaccines: a win-win-win situation, not a subsidy.
    Plahte J
    Lancet Infect Dis; 2005 Jan; 5(1):58-63. PubMed ID: 15620562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary.
    Behzad B; Jacobson SH; Sewell EC
    Expert Rev Vaccines; 2012 Oct; 11(10):1189-97. PubMed ID: 23176652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing immunization coverage.
    Hammer LD; Curry ES; Harlor AD; Laughlin JJ; Leeds AJ; Lessin HR; Rodgers CT; Granado-Villar DC; Brown JM; Cotton WH; Gaines BM; Gambon TB; Gitterman BA; Gorski PA; Kraft CA; Marino RV; Paz-Soldan GJ; Zind B; ;
    Pediatrics; 2010 Jun; 125(6):1295-304. PubMed ID: 20513736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytics for vaccine economics and pricing: insights and observations.
    Robbins MJ; Jacobson SH
    Expert Rev Vaccines; 2015 Apr; 14(4):605-16. PubMed ID: 25435003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
    Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term solutions for the problem of vaccine shortages.
    Lattanzi M; Rappuoli R
    Expert Opin Biol Ther; 2004 Jun; 4(6):989-92. PubMed ID: 15174980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine purchasing groups in the United States: An overview of their policies and practices.
    Cowan AE; Clark SJ; Gordon JL; Bok K; Shen AK
    Vaccine; 2016 Sep; 34(42):5060-5065. PubMed ID: 27614782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea.
    Sohn HS; Suh DC; Jang E; Kwon JW
    J Manag Care Pharm; 2010; 16(1):32-45. PubMed ID: 20044845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination planning and vaccine prices in a decentralizing country - Italy.
    Curto A; Duranti S; Van de Vooren K; Garattini L
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):195-202. PubMed ID: 24625038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of willingness to pay for self-paid vaccines in China.
    Hou Z; Jie Chang ; Yue D; Fang H; Meng Q; Zhang Y
    Vaccine; 2014 Jul; 32(35):4471-4477. PubMed ID: 24968160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.